NJR Steering Committee
(NJRSC)

The NJRSC is designated as an NHS England ‘Committee of Experts’ and our Chair reports directly to the Medical Director for NHS England. The NJRSC is responsible for setting our strategic direction and for overseeing the successful delivery of our work and closely managing the associated budget. The committee also oversees a supporting structure of eight sub-committees, each responsible for a dedicated area of NJR work and ensuring the delivery of work plans and development activities against agreed objectives.

Key responsibilities of the NJRSC are to ensure that:

  • Appropriate advice is provided to the Healthcare Quality Improvement Partnership, (the legal entity which hosts the NJR on behalf of NHS England Medical Directorate), on operational and financial matters;
  • The NJR budget is effectively managed and monitored;
  • The NJR sub-committee structure is fit for purpose and that all sub-committees have clear terms of reference, agreed composition, and defined purpose and responsibilities and report outcomes to the NJRSC regularly;
  • Outcomes achieved by brand of prostheses, hospital and surgeon are monitored and where these fall below expected performance, are highlighted to enable prompt investigation and follow-up by relevant implant suppliers, regulators, commissioners and providers of orthopaedic care;
  • Appropriate stakeholders (patients, clinicians, providers and commissioners of healthcare, regulators, professional societies and implant suppliers) are involved in and consulted on the work of the NJR as appropriate and informed of outcomes achieved in joint replacement surgery;
  • Patient awareness of joint replacement outcomes is enhanced to better inform patient choice and quality of experience, through engagement with patients, patient organisations and providers of care;
  • Evidence-based purchasing (quality and cost-effectiveness) of joint replacement implants by healthcare providers is supported;
  • Post-market surveillance of implants by key stakeholders (implant suppliers, the Medicines and Healthcare products Regulatory Agency, Beyond Compliance and Orthopaedic Devices Evaluation Panel) is supported;
  • Codes of conduct applied to NJR Contractor(s) in their relationship with key stakeholders are monitored;
  • Delivery and quality of work of NJR Contractors is effectively contract managed;
  • Accurate, relevant and timely data collected by the NJR, is made available to relevant regulators, commissioners and providers/suppliers of orthopaedic care, in an appropriate format, in order to support clinical governance and patient safety;
  • An annual report on the work of the NJR is published and made available in both the English and Welsh languages and in patient-friendly format;
  • Appropriate governance and monitoring arrangements are in place to facilitate the use of NJR data to support and enable related research;
  • NHS England (and devolved administrations as appropriate) is provided with advice on the NJR’s strategic direction, annual work programme and financial position (including annual review of subscription charges and any proposed change);
  • NHS England is updated on the performance of prostheses and good surgical practice, international collaboration work with other national orthopaedic joint registries, and any financial and/or intellectual property implications associated with the licensing of the ‘NJR brand’.

Click here for details about the NJR’s committee structure

Click here to access NJRSC meeting minutes

Committee Structure

Chair &
Vice Chair

Professor Sir Paul Curran

NJR Chair


Tim Wilton NJRSC

Tim Wilton

NJR Medical Director
Vice Chair, NJRSC

Chair and Medical Advisory Committees.

Members

Peter Howard

Mr Peter Howard

Orthopaedic Surgeon

Chair, Surgical Performance and Implant Scrutiny Committees.

Amar Rangan

Prof. Amar Rangan

Orthopaedic Surgeon

Mike Reed NJRSC

Prof. Mike Reed

Orthopaedic Surgeon

Chair, Editorial Committee.

Vacant

NHS Trust Manager

Mark Wilkinson

Prof. Mark Wilkinson

Public Health / Epidemiology

Chair, Research Committee.

Karen Barker

Prof. Karen Barker OBE

Practitioner with special interest in orthopaedics

Joshua Bridgens

Orthopaedic Implant
Manufacturer Representative

Jeff Stonadge

Jeff Stonadge

Orthopaedic Implant
Manufacturer Representative

Gillian Coward

Patient Representative

Robin Brittain

Robin Brittain

Patient Representative

Vacant

Independent Healthcare Provider

Co-opted members

Tim Briggs

Prof. Tim Briggs CBE

National Director for Clinical Improvement for NHSI/E
Chair, GIRFT Programme

Sharon Knight

Sharon Knight

Medicines and Healthcare products Regulatory Agency

Robin Rice NJRSC

Robin Rice

Welsh Government

Andy Smallwood

Andy Smallwood

NHS Procurement

John Skinner

Prof John Skinner

President, British Orthopaedic Association

Derek Pegg

Mr Derek Pegg

Orthopaedic Surgeon

Chair, Data Quality and Regional Clinical Coordinators Committee.

  •  
  •  
  •  
  •  
  •  
  •  
Scroll to Top